Can GLP-1 Drugs Help You Drink Less Alcohol? Here’s What The Latest Research Says

Can GLP-1 Drugs Help You Drink Less Alcohol? Here’s What The Latest Research Says

Written By :

,

Last Updated: June 25, 2026, 18:52 IST

A large observational study found that individuals on GLP-1s had substantially lower rates of developing alcohol use disorder compared to similar patients not taking the drugs.

Rapid Read

GLP-1 agonists mimic the glucagon-like peptide-1 hormone, which regulates blood sugar, slows digestion, and promotes feelings of fullness.

GLP-1 receptor agonists, popularly known as Ozempic, Wegovy, and similar medications, have already transformed obesity and type 2 diabetes treatment. Now, emerging research suggests these drugs may also influence addictive behaviours, including alcohol consumption.

While not yet approved for addiction treatment, studies indicate they could reduce cravings for alcohol and other substances by acting on brain reward pathways.

This potential dual benefit has sparked excitement in the medical community, especially as alcohol use disorders remain a major public health challenge worldwide. However, experts caution that more rigorous clinical trials are needed before these medications can be recommended for substance use issues.

What Are GLP-1 Drugs?

GLP-1 agonists mimic the glucagon-like peptide-1 hormone, which regulates blood sugar, slows digestion, and promotes feelings of fullness. Originally developed for diabetes, they gained fame for significant weight loss effects.

Beyond metabolic benefits, these drugs appear to modulate dopamine signalling and reward processing in the brain, which plays a central role in cravings for food, alcohol, and other substances.

Can GLP-1s Reduce Alcohol Consumption?

Early evidence is promising as human studies have shown that people taking GLP-1 medications tend to drink less alcohol. Animal research supports this, demonstrating reduced intake of alcohol as well as other substances.

A large observational study found that individuals on GLP-1s had substantially lower rates of developing alcohol use disorder compared to similar patients not taking the drugs.

What Does the Latest Research Show on Substance Use Disorders?

A 2026 study from the University of Texas at El Paso analysed over 142,000 patients with type 2 diabetes or obesity. Among the roughly 20,000 prescribed GLP-1 medications, researchers observed significantly reduced odds of developing multiple substance use disorders:

74% lower odds of alcohol use disorder

69% lower odds of opioid use disorder

68% lower odds of nicotine use disorder

75% lower odds of cocaine use disorder

These findings suggest GLP-1s may have broad effects on addiction-related pathways.

GLP-1s Effect On Brain’s Reward System And Addictive Behaviour

Traditional reward research has focused on dopamine centres like the ventral tegmental area and nucleus accumbens. However, new insights point to the lateral septum — a brain region rich in GLP-1 receptors — as a key player. This area helps process conscious thoughts about rewards and communicates with dopamine systems.

By activating GLP-1 receptors here, the drugs may dampen cravings and reduce the vivid mental imagery that drives addictive behaviours.

Despite encouraging observational data and mechanistic understanding, researchers stress that these medications are not yet proven or approved for treating addiction. The UTEP study was observational and cannot prove cause-and-effect. Randomised controlled trials are essential to confirm benefits, optimal dosing, and long-term safety for substance use disorders.

Potential side effects, cost, and accessibility remain concerns. Additionally, not everyone responds the same way to GLP-1s. Future research aims to track changes in substance use behaviours over time and explore how these drugs might improve overall mental health and quality of life in people with addiction.

GLP-1 medications represent an exciting intersection of metabolic and neurological science. While they are not a magic solution, they could become part of comprehensive treatment strategies for alcohol use and other addictions in the coming years. For now, anyone considering these drugs for drinking reduction should consult healthcare professionals rather than self-medicating.

As research advances, GLP-1s may offer new hope for millions struggling with alcohol and substance use disorders, potentially reshaping how we understand and treat addiction.

News18 Newsletter Handpicked stories, in your inbox A newsletter with the best of our journalism submit

First Published: June 25, 2026, 18:52 IST

News lifestyle health-and-fitness Can GLP-1 Drugs Help You Drink Less Alcohol? Here’s What The Latest Research Says